InsidersTradesSigma
Explore the full directors' dealings record of PROVECTUS BIOPHARMACEUTICALS, INC., a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €27.7m. The latest transaction was filed on 14 August 2024 (C). Among the most active insiders: Morris Jeffrey Allen. The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
2 of 2 declarations